NCT01470664View on ClinicalTrials.gov

FST-100 in the Treatment of Acute Adenoviral Conjunctivitis

PHASE2CompletedINTERVENTIONAL
Enrollment

176

Participants

Timeline

Start Date

December 17, 2012

Primary Completion Date

May 23, 2014

Study Completion Date

May 23, 2014

Conditions
Acute Adenoviral Conjunctivitis
Interventions
DRUG

FST-100

0.1% dexamethasone and 0.6% polyvinylpyrrolidone iodine (PVP-Iodine)

DRUG

FST-100 (Component #1)

0.6% PVP-Iodine ophthalmic solution alone

DRUG

FST-100 Vehicle

FST-100 Vehicle

Trial Locations (2)

201301

Ora, Inc., Noida

01810

Ora, Inc., Andover

Sponsors

Lead Sponsor

Shire
All Listed Sponsors
lead

Shire

INDUSTRY